Form D · Biotechnology
Bugworks Research, Inc.
Saratoga, CA · CIK 0001659031
Offering snapshot reported Mar 8, 2024 · SEC filing
- Reported sold
- $6.78M Offering amount: $15.8M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 22, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 8, 2024 | Initial | $6,779,976 | No comparison | 15 | SEC filing |
| Dec 1, 2021 | Initial | $15,974,632 | No comparison | 19 | SEC filing |
| Nov 13, 2020 | Initial | $6,249,998 | No comparison | 3 | SEC filing |
| Aug 17, 2018 | Initial | $8,454,866 | No comparison | 13 | SEC filing |
| Nov 20, 2015 | Initial | $1,607,380 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-507087
Source: Form D, filed Mar 8, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anand Anandkumar | Director, Executive |
| Santanu Datta | Director |
| Pradeep Fernandes | Executive |
| Tejasvi Ravi | Director |
| Venkataraman Subramanian | Director |
| Bala Subramanian | Director, Executive |
| Atsushi Usami | Director |
| Atushi Usami | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
13962 Pierce Road
Saratoga, CA, 95070
Saratoga, CA, 95070